Effects of maropitant in cats receiving dexmedetomidine and morphine

Manuel Martin-Flores Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Manuel Martin-Flores in
Current site
Google Scholar
PubMed
Close
 MV
,
Daniel M. Sakai Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Daniel M. Sakai in
Current site
Google Scholar
PubMed
Close
 MV
,
McKenzie M. Learn Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by McKenzie M. Learn in
Current site
Google Scholar
PubMed
Close
 ASC
,
Alicia Mastrocco Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Alicia Mastrocco in
Current site
Google Scholar
PubMed
Close
 BA
,
Luis Campoy Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Luis Campoy in
Current site
Google Scholar
PubMed
Close
 LV
,
Jordyn M. Boesch Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.
Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Jordyn M. Boesch in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Robin D. Gleed Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853.

Search for other papers by Robin D. Gleed in
Current site
Google Scholar
PubMed
Close
 BVSC, MA

Abstract

OBJECTIVE To evaluate the effects of maropitant in cats receiving dexmedetomidine and morphine.

DESIGN Randomized controlled trial.

ANIMALS 66 healthy female domestic shorthair cats.

PROCEDURES Cats were randomly assigned to receive maropitant (1 mg/kg [0.45 mg/lb], SC; maropitant group; n = 32) or saline (0.9% NaCl) solution (0.1 mL/kg [0.045 mL/lb], SC; control group; 34) 20 hours before IM administration of dexmedetomidine (20 μg/kg [9.1 μg/lb]) and morphine (0.1 mg/kg). Following administration of dexmedetomidine and morphine, the incidences of emesis, retching, and signs of nausea (sialorrhea and lip licking) were compared between the 2 groups. The aversive behavioral response of each cat to injection of maropitant or saline solution was scored on a visual analogue scale by each of 4 observers who were unaware of the treatment administered.

RESULTS Only 1 of 32 cats in the maropitant group vomited, whereas 20 of 34 control cats vomited. The incidences of emesis and retching for the maropitant group were significantly lower than those for the control group. The incidence of signs of nausea did not differ between the 2 groups. Visual analogue scale scores for the maropitant group were significantly higher than those for the control group.

CONCLUSIONS AND CLINICAL RELEVANCE Results of the present study indicated that administration of maropitant to healthy cats approximately 20 hours prior to administration of dexmedetomidine and morphine significantly decreased the incidence of emesis but did not decrease the incidence of signs of nausea. However, maropitant appeared to cause substantial discomfort when injected SC.

Abstract

OBJECTIVE To evaluate the effects of maropitant in cats receiving dexmedetomidine and morphine.

DESIGN Randomized controlled trial.

ANIMALS 66 healthy female domestic shorthair cats.

PROCEDURES Cats were randomly assigned to receive maropitant (1 mg/kg [0.45 mg/lb], SC; maropitant group; n = 32) or saline (0.9% NaCl) solution (0.1 mL/kg [0.045 mL/lb], SC; control group; 34) 20 hours before IM administration of dexmedetomidine (20 μg/kg [9.1 μg/lb]) and morphine (0.1 mg/kg). Following administration of dexmedetomidine and morphine, the incidences of emesis, retching, and signs of nausea (sialorrhea and lip licking) were compared between the 2 groups. The aversive behavioral response of each cat to injection of maropitant or saline solution was scored on a visual analogue scale by each of 4 observers who were unaware of the treatment administered.

RESULTS Only 1 of 32 cats in the maropitant group vomited, whereas 20 of 34 control cats vomited. The incidences of emesis and retching for the maropitant group were significantly lower than those for the control group. The incidence of signs of nausea did not differ between the 2 groups. Visual analogue scale scores for the maropitant group were significantly higher than those for the control group.

CONCLUSIONS AND CLINICAL RELEVANCE Results of the present study indicated that administration of maropitant to healthy cats approximately 20 hours prior to administration of dexmedetomidine and morphine significantly decreased the incidence of emesis but did not decrease the incidence of signs of nausea. However, maropitant appeared to cause substantial discomfort when injected SC.

All Time Past Year Past 30 Days
Abstract Views 335 0 0
Full Text Views 1763 1170 65
PDF Downloads 823 285 21
Advertisement